Cargando…
Acrodermatitis continua of Hallopeau: Is apremilast an efficacious treatment option?
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285779/ https://www.ncbi.nlm.nih.gov/pubmed/35261135 http://dx.doi.org/10.1111/dth.15423 |
| _version_ | 1784747859640320000 |
|---|---|
| author | Megna, Matteo Potestio, Luca Di Caprio, Nicola Tajani, Andrea Fabbrocini, Gabriella Annunziata, Alberto |
| author_facet | Megna, Matteo Potestio, Luca Di Caprio, Nicola Tajani, Andrea Fabbrocini, Gabriella Annunziata, Alberto |
| author_sort | Megna, Matteo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9285779 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley & Sons, Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92857792022-07-18 Acrodermatitis continua of Hallopeau: Is apremilast an efficacious treatment option? Megna, Matteo Potestio, Luca Di Caprio, Nicola Tajani, Andrea Fabbrocini, Gabriella Annunziata, Alberto Dermatol Ther Letters John Wiley & Sons, Inc. 2022-03-14 2022-05 /pmc/articles/PMC9285779/ /pubmed/35261135 http://dx.doi.org/10.1111/dth.15423 Text en © 2022 The Authors. Dermatologic Therapy published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Letters Megna, Matteo Potestio, Luca Di Caprio, Nicola Tajani, Andrea Fabbrocini, Gabriella Annunziata, Alberto Acrodermatitis continua of Hallopeau: Is apremilast an efficacious treatment option? |
| title | Acrodermatitis continua of Hallopeau: Is apremilast an efficacious treatment option? |
| title_full | Acrodermatitis continua of Hallopeau: Is apremilast an efficacious treatment option? |
| title_fullStr | Acrodermatitis continua of Hallopeau: Is apremilast an efficacious treatment option? |
| title_full_unstemmed | Acrodermatitis continua of Hallopeau: Is apremilast an efficacious treatment option? |
| title_short | Acrodermatitis continua of Hallopeau: Is apremilast an efficacious treatment option? |
| title_sort | acrodermatitis continua of hallopeau: is apremilast an efficacious treatment option? |
| topic | Letters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285779/ https://www.ncbi.nlm.nih.gov/pubmed/35261135 http://dx.doi.org/10.1111/dth.15423 |
| work_keys_str_mv | AT megnamatteo acrodermatitiscontinuaofhallopeauisapremilastanefficacioustreatmentoption AT potestioluca acrodermatitiscontinuaofhallopeauisapremilastanefficacioustreatmentoption AT dicaprionicola acrodermatitiscontinuaofhallopeauisapremilastanefficacioustreatmentoption AT tajaniandrea acrodermatitiscontinuaofhallopeauisapremilastanefficacioustreatmentoption AT fabbrocinigabriella acrodermatitiscontinuaofhallopeauisapremilastanefficacioustreatmentoption AT annunziataalberto acrodermatitiscontinuaofhallopeauisapremilastanefficacioustreatmentoption |